Coated medical devices and methods of making and using same
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61F-002/06
A61F-002/07
A61F-002/90
출원번호
US-0317587
(2014-06-27)
등록번호
US-9545301
(2017-01-17)
발명자
/ 주소
Wainwright, John
Mendelson, Todd
Haggstrom, Kurt
Molaei, Masoud
Schuman, Victoria
Sheu, Min-Shyan
출원인 / 주소
Covidien LP
대리인 / 주소
Kertz, Esq., Mark J.
인용정보
피인용 횟수 :
3인용 특허 :
108
초록▼
Coating methods and related devices are provided. Such devices can include stents. For example, the device can comprise a sidewall and a plurality of pores in the sidewall that are sized to inhibit flow of blood through the sidewall into an aneurysm to a degree sufficient to lead to thrombosis and h
Coating methods and related devices are provided. Such devices can include stents. For example, the device can comprise a sidewall and a plurality of pores in the sidewall that are sized to inhibit flow of blood through the sidewall into an aneurysm to a degree sufficient to lead to thrombosis and healing of the aneurysm when the tubular member is positioned in a blood vessel and adjacent to the aneurysm. The device can also comprise an anti-thrombogenic coating distributed over at least a portion of the device such that the pores are substantially free of webs formed by the coating.
대표청구항▼
1. A medical device for treating an aneurysm, comprising: a tubular member comprising a plurality of braided filaments that form a sidewall and a plurality of pores in the sidewall that are sized to inhibit flow of blood through the sidewall into an aneurysm to a degree sufficient to lead to thrombo
1. A medical device for treating an aneurysm, comprising: a tubular member comprising a plurality of braided filaments that form a sidewall and a plurality of pores in the sidewall that are sized to inhibit flow of blood through the sidewall into an aneurysm to a degree sufficient to lead to thrombosis and healing of the aneurysm when the tubular member is positioned in a blood vessel and adjacent to the aneurysm, each of the filaments crossing another of the filaments at a respective crossing point; andan antithrombogenic material distributed over the tubular member such that the pores are substantially free of webs formed by the material such that webs are present at fewer than 5% of the crossing points;wherein the tubular member exhibits an elapsed time before peak thrombin formation that is at least 1.5 times the elapsed time of an identical, uncoated tubular member. 2. The medical device of claim 1, wherein the pores have an average pore size that is less than or equal to about 500 microns when the member is in an expanded state. 3. The medical device of claim 1, wherein the pores have an average pore size that is less than or equal to about 320 microns when the member is in an expanded state. 4. The medical device of claim 3, wherein the pores have an average pore size that is measured using an inscribed circle diameter. 5. The medical device of claim 1, wherein the distribution of the antithrombogenic material is substantially complete over the tubular member. 6. The medical device of claim 5, wherein the anti thrombogenic material is generally uniform over the tubular member. 7. The medical device of any claim 1, wherein the distribution of the antithrombogenic material is substantially complete over at least a circumferential section of the tubular member that is 5 mm or more in length. 8. The medical device of claim 7, wherein the anti thrombogenic material comprises an antithrombogenic polymer. 9. The medical device of claim 8, wherein the anti thrombogenic polymer comprises MPC. 10. The medical device of claim 1, wherein the tubular member comprises a heat-set metallic braid. 11. The medical device of claim 1, wherein the tubular member is self-expanding. 12. The medical device of claim 1, wherein the tubular member has an open proximal end, an open distal end, and forms a lumen extending from the proximal end to the distal end. 13. The medical device of claim 1, wherein the tubular member exhibits an elapsed time before peak thrombin formation that is at least 2.5 times the elapsed time of an identical, uncoated tubular member. 14. The medical device of claim 1, wherein the tubular member has an expanded diameter, and an unexpanded diameter smaller than the expanded diameter, and the unexpanded diameter is 5 mm or less. 15. The medical device of claim 14, wherein the unexpanded diameter is 3 mm or less. 16. A delivery system for treating an aneurysm, the system comprising: an elongate core assembly comprising a tube, a wire, or a combination of a tube and a wire; andthe medical device of claim 1 engaged with the core assembly so as to be movable via the core assembly. 17. The delivery system of claim 16, further comprising a microcatheter configured to be implanted into a blood vessel, wherein the core assembly is configured to extend within the microcatheter. 18. The delivery system of claim 16, further comprising a polymeric member that engages an inner wall of the tubular member and enables longitudinal force transmission from the core assembly to the tubular member. 19. A medical device for treating an aneurysm, comprising: a tubular body configured to be implanted in a blood vessel and comprising a plurality of braided filaments, each of the filaments crossing another of the filaments at a respective crossing point, the body being expandable to an expanded state for treatment of the aneurysm, the body having a first section for spanning a neck of the aneurysm and a plurality of pores located between the filaments, the pores in the first section having a first average pore size of less than about 500 microns when the body is in the expanded state;the first section having a substantially complete distribution of an antithrombogenic material over the filaments;wherein the first section is substantially free of webs formed by the antithrombogenic material such that webs are present at fewer than 5% of the crossing points;wherein the tubular body exhibits an elapsed time before peak thrombin formation that is at least 1.5 times the elapsed time of an identical, uncoated tubular body. 20. The medical device of claim 19, wherein the first average pore size is less than or equal to about 320 microns when the body is in the expanded state. 21. The medical device of claim 19, wherein the first average pore size is measured using an inscribed circle diameter. 22. The medical device of claim 19, wherein the first average pore size is the average size of the pores in the first section without the antithrombogenic material. 23. The medical device of claim 19, wherein the first section comprises less than an entire length of the tubular body. 24. The medical device of claim 19, wherein the anti thrombogenic material on the first section is generally uniform over the filaments. 25. The medical device of claim 19, wherein the anti thrombogenic material comprises an antithrombogenic polymer. 26. The medical device of claim 25, wherein the anti thrombogenic polymer comprises MPC. 27. The medical device of claim 19, wherein the tubular body comprises a heat-set metallic braid. 28. The medical device of claim 19, wherein the tubular body is self-expanding. 29. The medical device of claim 19, wherein the tubular body has an open proximal end, an open distal end, and forms a lumen extending from the proximal end to the distal end. 30. The medical device of claim 19, wherein the tubular body exhibits an elapsed time before peak thrombin formation that is at least 2.5 times the elapsed time of an identical, uncoated tubular body. 31. The medical device of claim 19, wherein the tubular body has an expanded diameter, and an unexpanded diameter smaller than the expanded diameter, and the unexpanded diameter is 5 mm or less. 32. The medical device of claim 31, wherein the unexpanded diameter is 3 mm or less. 33. A delivery system for treating an aneurysm, the system comprising: an elongate core assembly comprising a tube, a wire, or a combination of a tube and a wire; andthe medical device of claim 19 engaged with the core assembly so as to be movable via the core assembly. 34. The delivery system of claim 33, further comprising a microcatheter configured to be implanted into a blood vessel, wherein the core assembly is configured to extend within the microcatheter. 35. The delivery system of claim 33, further comprising a polymeric member that engages an inner wall of the tubular body and enables longitudinal force transmission from the core assembly to the tubular body.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (108)
Morris, Grayson; Atladottir, Svava Maria; Pienknagura, Carla, Abluminal stent coating apparatus and method using a brush assembly.
Solomon Donald D. (Spring Valley OH) Byron M. Parke (Centerville OH), Anti-infective and antithrombogenic medical articles and method for their preparation.
Fearnot Neal E. (West Lafayette IN) Kozma Thomas G. (West Lafayette IN) Ragheb Anthony O. (West Lafayette IN) Voorhees William D. (West Lafayette IN), Coated implantable medical device.
Leon V. Rudakov ; Mir A. Imran ; Linh Dinh ; Ara Davidian ; Kevin T. Larkin, Composite expandable device with impervious polymeric covering and bioactive coating thereon, delivery apparatus and method.
Pham Pete P. (Fremont CA) Doan Hong (Santa Clara CA) Sepetka Ivan (Los Altos CA) Eder Joseph (Los Altos CA) Snyder Edward (San Jose CA), Electrolytically severable joint for endovascular embolic devices.
Alt Eckhard,DEX ; Fliedner Thilo,DEX ; Alter Robert,DEX ; Stemberger Axel,DEX, Implantable vascular and endoluminal stents and process of fabricating the same.
Fox ; Jr. Charles L. (New York NY) Modak Shanta M. (River Edge NJ) Sampath Lester A. (Nyack NY), Infection-resistant compositions, medical devices and surfaces and methods for preparing and using same.
Fox ; Jr. Charles L. (New York NY) Modak Shanta M. (River Edge NJ) Sampath Lester A. (Nyack NY), Infection-resistant compositions, medical devices and surfaces and methods for preparing and using same.
Fischell Robert E. (14600 Viburnum Dr. Dayton MD 21036) Fischell David R. (71 Riverlawn Dr. Fair Haven NJ 07704) Fischell Tim A. (1018 Chancery Dr. Nashville TN 37215), Multi-cell stent with cells having differing characteristics.
Hoffman Allan S. (King County WA) Garfinkle Andrew (King County WA) Ratner Buddy D. (King County WA) Hanson Stephen R. (San Diego County CA), Plasma gas discharge treatment for improving the biocompatibility of biomaterials.
Berry Dale T. ; Herald Coy M. ; Bates Brian L. ; Boatman Scott E. ; Hoffa Michael C. ; Fearnot Neal E. ; Voorhees ; III William D., Radially expandable stent.
Narayanan Pallassana V. (Davie FL) Stanley Kimberly D. (Florida City FL), Radiofrequency plasma treated polymeric surfaces having immobilized anti-thrombogenic agents.
Narayanan Pallassana V. (Davie FL) Stanley Kimberly D. (Florida City FL), Radiofrequency plasma treated polymeric surfaces having immobilized anti-thrombogenic agents.
Ragheb Anthony O. ; Bates Brian L. ; Fearnot Neal E. ; Osborne Thomas A. ; Kozma Thomas G. ; Roberts Joseph W. ; Voorhees ; III William D., Silver implantable medical device.
Dusbabek Andrew J. ; Ellis Louis G. ; Larson Christopher R. ; Brown Terry V. ; Euteneuer Charles L. ; Mertens Steven P. ; Mattison Richard C. ; Blaeser David J. ; Lorentzen Cornelius Linda R. ; Willa, Stent delivery system having stent securement apparatus.
Dusbabek, Andrew J.; Ellis, Louis G.; Larson, Christopher R.; Brown, Terry V.; Euteneuer, Charles L.; Mertens, Steven P.; Mattison, Richard C.; Blaeser, David J.; Lorentzen Cornelius, Linda R.; Willa, Stent delivery system having stent securement apparatus.
DeLaurentis Mark (Ocean Springs MS) Pourrezaei Kambiz (Dresher PA) Boxman Raymond L. (Herzliya NJ ILX) Beard Richard B. (Atco NJ), Urinary catheter and system.
Patnaik Birendra K. ; Lin Horng-Ban ; Lentz David J. ; Zdrahala Richard J., ePTFE small caliber vascular grafts with significant patency enhancement via a surface coating which contains covalently bonded heparin.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.